https://www.immunomica.com/articles/identification-of-significant-genes-and-pathways-related-to-lung-cancer-via-statistical-methods2018-vol-59-no-3-pp-224-242/ 2019-03-28T07:48:21+00:00 https://www.immunomica.com/articles/mitochondria-and-the-future-of-medicine-the-key-to-understanding-disease-chronic-illness-aging-and-life-itself-vol-45-no-2-pp-124-342/ 2019-03-28T07:59:25+00:00 https://www.immunomica.com/articles/this-is-your-brain-on-parasites-how-tiny-creatures-manipulate-our-behavior-and-shape-society-significant-vol-50-no-5-pp-214-222/ 2019-03-28T07:59:34+00:00 https://www.immunomica.com/articles/the-epigenetics-revolution-how-modern-biology-is-rewriting-our-understanding-of-genetics-disease-and-inheritancevol-80-no-7-pp-324-542/ 2019-03-28T07:59:45+00:00 https://www.immunomica.com/articles/identification-of-significant-genes-and-pathways-related-to-lung-cancer-via-statistical-methods2018-vol-59-no-3-pp-224-242-2/ 2019-03-28T08:00:09+00:00 https://www.immunomica.com/articles/identification-of-genetic-determinants-of-breast-cancer-immune-phenotypes-by-integrative-genome-scale-analysis/ 2021-11-12T13:47:51+00:00 https://www.immunomica.com/articles/oncogenic-states-dictate-the-prognostic-and-predictive-connotations-of-intratumoral-immune-response/ 2021-11-12T13:48:12+00:00 https://www.immunomica.com/articles/the-combination-of-neoantigen-quality-and-t-lymphocyte-infiltrates-identifies-glioblastomas-with-the-longest-survival/ 2021-11-12T13:49:20+00:00 https://www.immunomica.com/articles/a-balance-score-between-im-mune-stimulatory-and-suppressive-microenvironments-identifies-mediators-of-tumor-immunity-and-predicts-pan-cancer-survival/ 2021-11-12T13:50:13+00:00 https://www.immunomica.com/articles/toward-a-comprehensive-view-of-cancer-immune-responsiveness-a-synopsis-from-the-sitc-workshop/ 2021-11-12T13:51:01+00:00 https://www.immunomica.com/articles/evolution-of-metastases-in-space-and-time-under-immune-selection/ 2021-11-12T13:51:54+00:00 https://www.immunomica.com/articles/he-immunologic-constant-of-rejection-classification-refines-the-prognostic-value-of-conventional-prognostic-signatures-in-breast-cancer/ 2021-11-12T13:52:39+00:00 https://www.immunomica.com/articles/the-immune-landscape-of-cancer/ 2021-11-12T13:53:16+00:00 https://www.immunomica.com/articles/prediction-of-response-to-anticancer-immunotherapy-using-gene-signatures/ 2021-11-12T13:54:11+00:00 https://www.immunomica.com/articles/ligand-significantly-augments-immune-responses-to-a-dendritic-cell-targeting-anti-dec-205-ny-eso-1-vaccine-through-expansion-of-dendritic-cell-subsets/ 2021-11-12T13:55:15+00:00 https://www.immunomica.com/articles/germline-genetic-contribution-to-the-immune-landscape-of-cancer/ 2021-11-12T13:56:05+00:00 https://www.immunomica.com/articles/a-multi-layer-molecular-fresco-of-the-immune-diversity-across-hematologic-malignancies/ 2021-11-12T13:56:31+00:00 https://www.immunomica.com/articles/molecular-profiling-reveals-biologically-discrete-subsets-and-pathways-of-progression-in-diffuse-glioma/ 2021-11-12T13:56:59+00:00 https://www.immunomica.com/articles/the-continuum-of-cancer-immunosurveillance-prognostic-predictive-and-mechanistic-signatures/ 2021-11-12T14:02:08+00:00 https://www.immunomica.com/articles/expression-is-associated-with-immune-signatures-and-basal-like-phenotype-in-breast-cancer/ 2021-11-12T14:04:57+00:00 https://www.immunomica.com/articles/cxcr3-ccr5-pathways-in-metastatic-melanoma-patients-treated-with-adoptive-therapy-and-interleukin-2/ 2021-11-12T14:05:13+00:00 https://www.immunomica.com/articles/transcriptomic-profiles-conducive-to-immune-mediated-tumor-rejection-in-human-breast-cancer-skin-metastases-treated-with-imiquimod/ 2021-11-12T14:05:43+00:00